Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Open in API
Filings indexed 794 across all filing types
Latest filing 2023-11-27 Share Issue/Capital Cha…
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Vita 34 AG: resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors
Share Issue/Capital Change Classification · 98% confidence The document is an 'Ad-hoc' announcement dated November 27, 2023, disclosing a resolution by Vita 34 AG to execute a 'cash capital increase under exclusion of subscription rights' involving the issuance of new shares to investors. This action directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it involves shares, it is a primary financing event rather than a routine share repurchase (POS) or a general share issue announcement (SHA), making CAP the most specific fit for a capital raise via private placement.
2023-11-27 English
Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development
Earnings Release Classification · 100% confidence The document is a news release dated November 24, 2023, explicitly stating key financial results for 'Q3 2023' and the 'first nine months of 2023'. It contains summary financial figures (Revenue, EBITDA) and confirms the guidance for the fiscal year 2023. The presence of 'Quarter Results' as a keyword and the focus on period-specific financial performance (Q3/9M) strongly indicates this is an initial announcement of periodic results, rather than a comprehensive annual report (10-K) or a detailed interim report (IR). It fits the definition of an Earnings Release (ER). It is not a short announcement linking to a full report, as it contains substantial data and analysis, thus bypassing the RPA/RNS rule. 9M 2023
2023-11-24 English
Q3 statement / Q3 financial report 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Statement' for the period January to September 2023, issued by Vita 34 AG. It contains detailed financial statements (Income statement, Balance sheet, Cash flow), management discussion and analysis of business segments, and performance metrics. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-24 English
Q3 statement / Q3 financial report 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Statement' for the period January to September 2023, issued by Vita 34 AG. It contains detailed financial statements (Income statement, Balance sheet, Cash flow), management discussion and analysis of business segments, and performance metrics. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-24 English
Report Publication Announcement 2023
Report Publication Announcement Classification · 100% confidence The document is titled 'Preliminary announcement of the publication of quarterly reports and quarterly/interim statements'. It explicitly states that the company 'hereby announces that the following financial reports shall be disclosed' and provides future dates and links for the actual disclosure of the 'Quarterly/ Interim statement'. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement about the future publication of a report, rather than the report itself, should be classified as a Report Publication Announcement (RPA). The document is very short (1848 chars) and serves only to announce the upcoming release of the interim financial statement.
2023-11-17 English
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.07.2023 bis zum 30.09.2023
Report Publication Announcement Classification · 100% confidence The document is a short notification (806 characters) announcing the availability of a quarterly report ('Zwischenmitteilung') for the period 01.07.2023 to 30.09.2023. It provides a link to the website where the actual report can be found and specifies the publication date. Per the 'Menu vs Meal' rule, since this is a short announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2023-11-17 German

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.